Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $2.17 Million - $2.51 Million
21,600 Added 257.14%
30,000 $3.34 Million
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $873,096 - $999,432
8,400 New
8,400 $896,000
Q4 2021

Feb 11, 2022

SELL
$119.87 - $145.67 $5.39 Million - $6.56 Million
-45,000 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$128.64 - $184.79 $2.65 Million - $3.81 Million
-20,600 Reduced 31.4%
45,000 $5.86 Million
Q2 2021

Aug 16, 2021

SELL
$160.2 - $186.42 $3.91 Million - $4.55 Million
-24,400 Reduced 27.11%
65,600 $11.7 Million
Q3 2020

Nov 16, 2020

BUY
$105.46 - $144.13 $9.49 Million - $13 Million
90,000 New
90,000 $12.8 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.63B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.